Previous sessionNext session Striving towards the future elimination of Hep C among people who use drugs Futures zone 1 (F1) In programme Thursday, 24 October, 2019 - 16:50 to 18:20 View presentations Chair SchatzEberhard Correlation European Harm Reduction NetworkNetherlands RouxPerrine INSERMFrance Tracks The future of hepatitis C among people who inject drugs: new frontiers for policy, practice and science Keywords MethodsInfectious diseasesPolicyTreatment: medical/pharmacologicalPreventionPublic healthOpiates Presentations Plenary session Poster session Big debate Structured session Workshop Oral presentation session Short communication session Poster guided tour Thursday, 24 October 16:50 Oral presentation A community-based peer-driven program to reach people who inject drugs, monitor risk behaviours and 'test and treat' for infectious diseases in Athens, Greece: ARISTOTLE HCV-HIV 16:50 to 17:05 Futures zone 1 (F1) Vana Sypsa 17:05 Oral presentation Uptake of testing, linkage to care, and treatment for hepatitis C infection among people who inject drugs in Australia: the ETHOS Engage Study 17:05 to 17:20 Futures zone 1 (F1) Jason Grebely 17:20 Oral presentation Low HCV-RNA prevalence and low anti HCV incidence in a large national sample of PWID in opioid substitution treatment in Germany: a prospective cohort study 17:20 to 17:35 Futures zone 1 (F1) Bernd Schulte 17:35 Oral presentation Monitoring the elimination of hepatitis C and B among people who inject drugs in Europe 17:35 to 17:50 Futures zone 1 (F1) Thomas Seyler 17:50 Oral presentation 'Towards eliminating viral hepatitis': A critical examination of the performativity of hepatitis C elimination goals and targets 17:50 to 18:05 Futures zone 1 (F1) Kari Lancaster 18:05 Oral presentation Evidencing viral elimination futures: modelling, targets and the end of Hep C 18:05 to 18:20 Futures zone 1 (F1) Tim Rhodes
